Purchase Order W81K0220P0149
Award Date 10/1/20
Potential Completion Date 9/30/23
Potential Value $546K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Portage, MI 49002, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order contract awarded by the Department of the Army Medical Command to Phadia US Inc., a subsidiary of Thermo Fisher Scientific, for the delivery of $146,363.76 in allergen detection equipment and reagents. Phadia is a provider of allergy and autoimmune testing solutions, and has previously supplied allergy testing analyzers, reagents, and associated consumables to Department of Defense health agencies and facilities to support their medical readiness...
- This is a federal contract award to Phadia US Inc., a subsidiary of Thermo Fisher Scientific, to provide reagents required for allergy testing. The contract is a Blanket Purchase Agreement (BPA) Call with the Defense Health Agency, a defense agency, with a ceiling value of $24,960.42 and a completion date of September 30, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation. Phadia US Inc. is a foreign-owned, for-profit organization that specializes in...
- The Defense Health Agency awarded a mission-critical contract to Phadia US Inc.'s Immunodiagnostics Division on August 1, 2025, valued at $49,920.38 through a Blanket Purchase Agreement (BPA) call. This firm-fixed-price order procures specialized allergy testing reagents required to support healthcare providers across San Antonio military treatment facilities and other Department of Defense medical installations. The reagents are essential for the detection and management of allergic...
- This is a firm-fixed-price contract awarded by the Defense Health Agency to Phadia US Inc., a subsidiary of Thermo Fisher Scientific, for the manufacture of in-vitro diagnostic substances. The $24,960.42 contract has a period of performance through September 30, 2025 and was awarded on June 17, 2025 without a set-aside designation. Phadia US Inc. specializes in advanced allergy and autoimmune testing solutions, providing IMMUNOCAP SYSTEM ANALYZERS and related equipment, software, supplies,...
- This is a firm-fixed-price BPA call awarded by the U.S. Army Medical Command (MEDCOM) to Phadia US Inc., a subsidiary of Thermo Fisher Scientific, for $600,000.00. The contract is for the provision of immunodiagnostic analyzers, reagents, and consumables used for allergen and asthma testing to support military medical readiness and research programs. Phadia has received numerous prime federal contract awards from agencies like the Defense Health Agency and Department of the Air Force for its...
- This is a firm-fixed-price Blanket Purchase Agreement (BPA) call order awarded by the U.S. Army Medical Command (MEDCOM) to Phadia US Inc., a subsidiary of Thermo Fisher Scientific, for $600,000.00. The BPA call is for allergy and asthma testing solutions, including analyzers, reagents, and consumables to support military medical readiness and research programs. Phadia US Inc. has been the sole source provider for many similar MEDCOM contracts due to its proprietary products being the only...
- The Department of the Army Medical Command awarded a $892,500 firm fixed price purchase order to Phadia US Inc. Immunodiagnostics Division for autoimmune and allergy testing reagents with an analyzer. The prime contractor, Phadia US, is a division of Thermo Electron Corporation Financial Services. The contract has a period of performance from May 29, 2020 through May 31, 2025. The place of performance will be in Germany. This purchase order supports the Army Medical Command's mission to...
- This is a firm-fixed-price Blanket Purchase Agreement (BPA) call awarded by the Defense Health Agency (DHA) to Phadia US Inc., a subsidiary of Thermo Fisher Scientific, for the supply of PHADIA IMMUNOCAP SPEC IGE diagnostic equipment, reagents, and related services. The contract has a ceiling value of $24,960.42 and a period of performance through September 30, 2025. Phadia US Inc. is a foreign-owned, for-profit organization that specializes in providing advanced allergy and autoimmune testing...
- The Department of the Army Medical Command awarded a $3.15 million firm fixed price purchase order to Phadia US Inc. Immunodiagnostics Division for allergen and asthma testing requirements. The prime contractor will provide immunodiagnostic analyzers, reagents, and consumables to support the agency's testing needs through August 2025. The solicitation sought these products and services to advance the Defense Health Agency's Risk Management Framework and Authority to Operate guidelines. Performed...
- This federal contract award with ID FA301624A0046|HT009025FG0430018 was issued by the Defense Health Agency to Phadia US Inc., a subsidiary of Thermo Fisher Scientific, for the provision of IMMUNOCAP SPEC products. The contract is a Blanket Purchase Agreement (BPA) Call with a firm-fixed-price of $49,921.04 and a performance period ending on September 30, 2025. Phadia US Inc. is a foreign-owned, for-profit organization that specializes in advanced allergy and autoimmune testing solutions, and...